Meramonte, Lorna D.

HRN: 28-88-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2026
04/23/2026
IV
4.5g
Q8
CAPMR
Pending Pharmacy Acceptance 

 Indication:  Empiric Then Culture-directed    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: